652.75
-13.55
(-2.03%)
At close: April 17 at 3:29:58 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
44,193,340
38,910,210
36,076,690
30,220,560
32,511,550
Cost of Revenue
18,893,990
17,251,800
17,008,130
15,832,840
14,087,800
Gross Profit
25,299,350
21,658,410
19,068,560
14,387,720
18,423,750
Operating Expense
18,187,840
16,838,790
17,639,750
16,805,230
14,211,040
Operating Income
7,111,510
4,819,620
1,428,810
-2,417,510
4,212,710
Net Non Operating Interest Income Expense
-2,742,140
-2,848,030
-1,866,350
-682,910
-1,234,040
Pretax Income
4,070,760
-1,169,440
-2,862,000
-6,525,130
2,754,390
Tax Provision
717,580
315,900
-553,010
-1,782,630
316,510
Net Income Common Stockholders
35,294,350
-706,140
-2,026,350
-4,602,110
2,684,420
Diluted NI Available to Com Stockholders
35,294,350
-706,140
-2,026,350
-4,602,110
2,684,420
Basic EPS
383.84
-7.76
-22.49
-51.28
29.96
Diluted EPS
383.80
-7.76
-22.49
-51.28
29.92
Basic Average Shares
91,955.09
91,001.82
90,080.78
89,747.53
89,609.61
Diluted Average Shares
92,087.05
91,126.56
90,085.61
89,786.47
89,709.40
Rent Expense Supplemental
--
157,610
144,020
80,890
71,960
Total Expenses
37,081,830
34,090,590
34,647,880
32,638,070
28,298,840
Net Income from Continuing & Discontinued Operation
35,294,350
-706,140
-2,026,350
-4,602,110
2,684,420
Normalized Income
2,464,606.45
-152,427
-2,107,764.33
-2,892,038.55
2,064,132.35
Interest Income
--
296,420
745,070
1,084,530
353,010
Interest Expense
2,621,400
2,727,290
2,175,910
1,457,240
1,330,400
Net Interest Income
-2,742,140
-2,848,030
-1,866,350
-682,910
-1,234,040
EBIT
6,692,160
1,557,850
-686,090
-5,067,890
4,084,790
EBITDA
8,675,930
3,764,680
1,746,430
-2,737,750
6,147,660
Reconciled Cost of Revenue
18,893,990
17,251,800
17,008,130
15,832,840
14,087,800
Reconciled Depreciation
1,983,770
2,206,830
2,432,520
2,330,140
2,062,870
Net Income from Continuing Operation Net Minority Interest
3,424,170
-1,248,340
-2,212,040
-4,602,110
2,545,010
Total Unusual Items Excluding Goodwill
1,164,910
-1,565,590
-129,250
-2,352,860
543,310
Total Unusual Items
1,164,910
-1,565,590
-129,250
-2,352,860
543,310
Normalized EBITDA
7,511,020
5,330,270
1,875,680
-384,890
5,604,350
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
205,346.45
-469,677
-24,974.33
-642,788.55
62,432.35
3/31/2021 - 6/8/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
UNICHEMLAB.BO Unichem Laboratories Limited
614.35
-1.37%
SUVEN.BO Suven Life Sciences Limited
126.30
-0.51%
AMBALALSA.BO Ambalal Sarabhai Enterprises Limited
39.16
+0.72%
PPLPHARMA.BO Piramal Pharma Limited
220.15
-0.74%
BAJAJHCARE.NS Bajaj HealthCare Limited
622.15
+0.04%
AUROPHARMA.BO Aurobindo Pharma Limited
1,171.95
+3.46%
GRANULES.NS Granules India Limited
467.50
+0.96%
WOCKPHARMA.NS Wockhardt Limited
1,413.80
+1.54%